Johnson & Johnson could axe up to 8,000 jobs as part of a new cost cutting initiative. The cuts, said the company, are designed to consolidate its position as the world’s leading healthcare company and help it battle competition in the pharma market. The company estimates ...
Please Login to read the full article.
